Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease

Abstract 5-methylcytosine and the oxidation product 5-hydroxymethylcytosine are two prominent epigenetic variants of the cytosine base in nuclear DNA of mammalian brains. We measured levels of 5-methylcytosine and 5-hydroxymethylcytosine by enzyme-linked immunosorbent assay in DNA from post-mortem c...

Full description

Bibliographic Details
Main Authors: Reinhard Stöger, Paula J. Scaife, Freya Shephard, Lisa Chakrabarti
Format: Article
Language:English
Published: Nature Portfolio 2017-02-01
Series:npj Parkinson's Disease
Online Access:https://doi.org/10.1038/s41531-017-0007-3
_version_ 1827614932017872896
author Reinhard Stöger
Paula J. Scaife
Freya Shephard
Lisa Chakrabarti
author_facet Reinhard Stöger
Paula J. Scaife
Freya Shephard
Lisa Chakrabarti
author_sort Reinhard Stöger
collection DOAJ
description Abstract 5-methylcytosine and the oxidation product 5-hydroxymethylcytosine are two prominent epigenetic variants of the cytosine base in nuclear DNA of mammalian brains. We measured levels of 5-methylcytosine and 5-hydroxymethylcytosine by enzyme-linked immunosorbent assay in DNA from post-mortem cerebella of individuals with Parkinson’s disease and age-matched controls. 5-methylcytosine levels showed no significant differences between Parkinson’s disease and control DNA sample sets. In contrast, median 5-hydroxymethylcytosine levels were almost twice as high (p < 0.001) in both male and female Parkinson’s disease individuals compared with controls. The distinct epigenetic profile identified in cerebellar DNA of Parkinson’s disease patients raises the question whether elevated 5-hydroxymethylcytosine levels are a driver or a consequence of Parkinson’s disease.
first_indexed 2024-03-09T09:01:56Z
format Article
id doaj.art-313bead6c40041298b4aafaba6c38a62
institution Directory Open Access Journal
issn 2373-8057
language English
last_indexed 2024-03-09T09:01:56Z
publishDate 2017-02-01
publisher Nature Portfolio
record_format Article
series npj Parkinson's Disease
spelling doaj.art-313bead6c40041298b4aafaba6c38a622023-12-02T11:14:03ZengNature Portfolionpj Parkinson's Disease2373-80572017-02-01311310.1038/s41531-017-0007-3Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s diseaseReinhard Stöger0Paula J. Scaife1Freya Shephard2Lisa Chakrabarti3School of Biosciences, University of NottinghamSchool of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences, University of NottinghamSchool of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences, University of NottinghamSchool of Veterinary Medicine and Science, Faculty of Medicine and Health Sciences, University of NottinghamAbstract 5-methylcytosine and the oxidation product 5-hydroxymethylcytosine are two prominent epigenetic variants of the cytosine base in nuclear DNA of mammalian brains. We measured levels of 5-methylcytosine and 5-hydroxymethylcytosine by enzyme-linked immunosorbent assay in DNA from post-mortem cerebella of individuals with Parkinson’s disease and age-matched controls. 5-methylcytosine levels showed no significant differences between Parkinson’s disease and control DNA sample sets. In contrast, median 5-hydroxymethylcytosine levels were almost twice as high (p < 0.001) in both male and female Parkinson’s disease individuals compared with controls. The distinct epigenetic profile identified in cerebellar DNA of Parkinson’s disease patients raises the question whether elevated 5-hydroxymethylcytosine levels are a driver or a consequence of Parkinson’s disease.https://doi.org/10.1038/s41531-017-0007-3
spellingShingle Reinhard Stöger
Paula J. Scaife
Freya Shephard
Lisa Chakrabarti
Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
npj Parkinson's Disease
title Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
title_full Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
title_fullStr Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
title_full_unstemmed Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
title_short Elevated 5hmC levels characterize DNA of the cerebellum in Parkinson’s disease
title_sort elevated 5hmc levels characterize dna of the cerebellum in parkinson s disease
url https://doi.org/10.1038/s41531-017-0007-3
work_keys_str_mv AT reinhardstoger elevated5hmclevelscharacterizednaofthecerebelluminparkinsonsdisease
AT paulajscaife elevated5hmclevelscharacterizednaofthecerebelluminparkinsonsdisease
AT freyashephard elevated5hmclevelscharacterizednaofthecerebelluminparkinsonsdisease
AT lisachakrabarti elevated5hmclevelscharacterizednaofthecerebelluminparkinsonsdisease